Intuitive, Reproducible High-Throughput Molecular Dynamics in Galaxy: a Tutorial
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Rdock Reference Guide Rdock Development Team August 27, 2015 Contents
rDock Reference Guide rDock Development Team August 27, 2015 Contents 1 Preface 4 2 Acknowledgements 4 3 Introduction 4 4 Configuration 4 5 Cavity mapping 6 5.1 Two sphere method . 6 5.2 Reference ligand method . 8 6 Scoring function reference 11 6.1 Component Scoring Functions . 11 6.1.1 van der Waals potential . 11 6.1.2 Empirical attractive and repulsive polar potentials . 11 6.1.3 Solvation potential . 12 6.1.4 Dihedral potential . 13 6.2 Intermolecular scoring functions under evaluation . 13 6.2.1 Training sets . 13 6.2.2 Scoring Functions Design . 13 6.2.3 Scoring Functions Validation . 14 6.3 Code Implementation . 15 7 Docking protocol 17 7.1 Protocol Summary . 17 7.1.1 Pose Generation . 17 7.1.2 Genetic Algorithm . 17 7.1.3 Monte Carlo . 17 7.1.4 Simplex . 18 7.2 Code Implementation . 18 7.3 Standard rDock docking protocol (dock.prm) . 18 8 System definition file reference 22 8.1 Receptor definition . 22 8.2 Ligand definition . 23 8.3 Solvent definition . 24 8.4 Cavity mapping . 25 8.5 Cavity restraint . 27 8.6 Pharmacophore restraints . 27 8.7 NMR restraints . 28 8.8 Example system definition files . 28 9 Molecular files and atoms typing 30 9.1 Atomic properties. 30 9.2 Difference between formal charge and distributed formal charge . 30 9.3 Parsing a MOL2 file . 31 9.4 Parsing an SD file . 31 9.5 Assigning distributed formal charges to the receptor . 31 10 rDock file formats 32 10.1 .prm file format . -
Open Babel Documentation Release 2.3.1
Open Babel Documentation Release 2.3.1 Geoffrey R Hutchison Chris Morley Craig James Chris Swain Hans De Winter Tim Vandermeersch Noel M O’Boyle (Ed.) December 05, 2011 Contents 1 Introduction 3 1.1 Goals of the Open Babel project ..................................... 3 1.2 Frequently Asked Questions ....................................... 4 1.3 Thanks .................................................. 7 2 Install Open Babel 9 2.1 Install a binary package ......................................... 9 2.2 Compiling Open Babel .......................................... 9 3 obabel and babel - Convert, Filter and Manipulate Chemical Data 17 3.1 Synopsis ................................................. 17 3.2 Options .................................................. 17 3.3 Examples ................................................. 19 3.4 Differences between babel and obabel .................................. 21 3.5 Format Options .............................................. 22 3.6 Append property values to the title .................................... 22 3.7 Filtering molecules from a multimolecule file .............................. 22 3.8 Substructure and similarity searching .................................. 25 3.9 Sorting molecules ............................................ 25 3.10 Remove duplicate molecules ....................................... 25 3.11 Aliases for chemical groups ....................................... 26 4 The Open Babel GUI 29 4.1 Basic operation .............................................. 29 4.2 Options ................................................. -
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
processes Review Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development Outi M. H. Salo-Ahen 1,2,* , Ida Alanko 1,2, Rajendra Bhadane 1,2 , Alexandre M. J. J. Bonvin 3,* , Rodrigo Vargas Honorato 3, Shakhawath Hossain 4 , André H. Juffer 5 , Aleksei Kabedev 4, Maija Lahtela-Kakkonen 6, Anders Støttrup Larsen 7, Eveline Lescrinier 8 , Parthiban Marimuthu 1,2 , Muhammad Usman Mirza 8 , Ghulam Mustafa 9, Ariane Nunes-Alves 10,11,* , Tatu Pantsar 6,12, Atefeh Saadabadi 1,2 , Kalaimathy Singaravelu 13 and Michiel Vanmeert 8 1 Pharmaceutical Sciences Laboratory (Pharmacy), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland; ida.alanko@abo.fi (I.A.); rajendra.bhadane@abo.fi (R.B.); parthiban.marimuthu@abo.fi (P.M.); atefeh.saadabadi@abo.fi (A.S.) 2 Structural Bioinformatics Laboratory (Biochemistry), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland 3 Faculty of Science-Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands; [email protected] 4 Swedish Drug Delivery Forum (SDDF), Department of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden; [email protected] (S.H.); [email protected] (A.K.) 5 Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7 A, FI-90014 Oulu, Finland; andre.juffer@oulu.fi 6 School of Pharmacy, University of Eastern Finland, FI-70210 Kuopio, Finland; maija.lahtela-kakkonen@uef.fi (M.L.-K.); tatu.pantsar@uef.fi -
Ee9e60701e814784783a672a9
International Journal of Technology (2017) 4: 611‐621 ISSN 2086‐9614 © IJTech 2017 A PRELIMINARY STUDY ON SHIFTING FROM VIRTUAL MACHINE TO DOCKER CONTAINER FOR INSILICO DRUG DISCOVERY IN THE CLOUD Agung Putra Pasaribu1, Muhammad Fajar Siddiq1, Muhammad Irfan Fadhila1, Muhammad H. Hilman1, Arry Yanuar2, Heru Suhartanto1* 1Faculty of Computer Science, Universitas Indonesia, Kampus UI Depok, Depok 16424, Indonesia 2Faculty of Pharmacy, Universitas Indonesia, Kampus UI Depok, Depok 16424, Indonesia (Received: January 2017 / Revised: April 2017 / Accepted: June 2017) ABSTRACT The rapid growth of information technology and internet access has moved many offline activities online. Cloud computing is an easy and inexpensive solution, as supported by virtualization servers that allow easier access to personal computing resources. Unfortunately, current virtualization technology has some major disadvantages that can lead to suboptimal server performance. As a result, some companies have begun to move from virtual machines to containers. While containers are not new technology, their use has increased recently due to the Docker container platform product. Docker’s features can provide easier solutions. In this work, insilico drug discovery applications from molecular modelling to virtual screening were tested to run in Docker. The results are very promising, as Docker beat the virtual machine in most tests and reduced the performance gap that exists when using a virtual machine (VirtualBox). The virtual machine placed third in test performance, after the host itself and Docker. Keywords: Cloud computing; Docker container; Molecular modeling; Virtual screening 1. INTRODUCTION In recent years, cloud computing has entered the realm of information technology (IT) and has been widely used by the enterprise in support of business activities (Foundation, 2016). -
Evaluation of Protein-Ligand Docking Methods on Peptide-Ligand
bioRxiv preprint doi: https://doi.org/10.1101/212514; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Evaluation of protein-ligand docking methods on peptide-ligand complexes for docking small ligands to peptides Sandeep Singh1#, Hemant Kumar Srivastava1#, Gaurav Kishor1#, Harinder Singh1, Piyush Agrawal1 and G.P.S. Raghava1,2* 1CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India. 2Indraprastha Institute of Information Technology, Okhla Phase III, Delhi India #Authors Contributed Equally Emails of Authors: SS: [email protected] HKS: [email protected] GK: [email protected] HS: [email protected] PA: [email protected] * Corresponding author Professor of Center for Computation Biology, Indraprastha Institute of Information Technology (IIIT Delhi), Okhla Phase III, New Delhi-110020, India Phone: +91-172-26907444 Fax: +91-172-26907410 E-mail: [email protected] Running Title: Benchmarking of docking methods 1 bioRxiv preprint doi: https://doi.org/10.1101/212514; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT In the past, many benchmarking studies have been performed on protein-protein and protein-ligand docking however there is no study on peptide-ligand docking. -
Computer-Aided Drug Design: a Practical Guide
Computer-Aided Drug Design: A Practical Guide Forrest Smith, Ph.D. Department of Drug Discovery and Development Harrison School of Pharmacy Auburn, University History of Drug Design • Natural Products-Ebers Papyrus, 1500 B.C. documents over 700 plant based products used to treat a variety of illnesses • The rise of Organic Chemistry, middle or the 20th Century, semi-synthetic and synthetic drugs • Computers emerge in the late 1980s, CADD with minimal impact • Automation in the 1990s, High Through-put Screening and Robotics, Compound Libraries • CADD has continued to advance since its introduction with improving capabilities Computational Chemistry • Ab initio calculations • Semi-empirical calculations • Molecular Mechanics Molecular Mechanics Global Minimum Force Fields • MM2, MM3, MM4 • MMFF • AMBER • CHARM • OPLS Finding the Global Minimum • Systematic Search • Monte Carlo Methods • Simulated Annealing • Quenched Dynamics Minor Groove Binders Computer-Aided Drug Design • Structure Based Design – Docking – Molecular Dynamics – Free Energy Perturbation • Ligand Based Design-QSAR – COMFA – Pharmacophore Modeling – Shape Based Methods Docking-The Receptor • X-Ray Crystal Structures – RCSB Protein Data Bank (https://www.rcsb.org/) – Private Data • Homology Modeling • Nuclear Magnetic Resonance Docking- The Ligand • Proprietary Ligands • Databases qReal Databases • FDA approved drugs- (http://chemoinfo.ipmc.cnrs.fr/MOLDB/index.html) • Purchasable compounds Zinc 15, currently 100 million compounds (http://zinc15.docking.org/) q Virtual Databases- -
Ftitr Tutirgr Held Thuraday
San Jon, Cal. fhit 31nsr Pasffie Game Subs Rate, $1.00 Rally to be Per Quarter ftitr Tutirgr Held Thuraday 2 2 X! I . J1,1-1 11.1FURNiA, WED \ I --1).\1., (2LI OBER II, 19i; r_12 Attractive Program for NOTICE Concert Series Tickets Placed on In order to choose a yell leader Pre-game Rally Planned; for the coming year, an election Sale Today, Committee Announces; will be held in front of the Morris Dailey auditorium all dily today, Parade Will Climax Fun Wednesday, October II. Presi- Naom Blinder, Violinist, Here Nov. 7 dent Covello asks every tudent Wildest Event of Evening Will to cooperate by voting. The Car.- Probably Be Parade Thru Leads Rally Famous Violinist To Appear Concert Series Tickets Sale didate re Howard Burns and Enthusiasm Downtown San Jose 7 (,hairman Shown Jim Hamilton. At S. J. State Nov. 'psis By Students Will In Music Program Dud DeGroot and Team - - -- Speeches During Alice Dixon Heads Conimittee Give \ the initial concert in the IO33- +4 Rally In Auditorium E. Higgins Of Music Department _ _ Plans rie, San Jose State music 'rivers will Concert &ries iniee the opportunity to bear Naom di,. ,rantest pre -game rally in the Radio Pep Rally Blinder. famous violinist, N9V. 7. ot San Jose State will be held in The tickets tor 'la Blinder is now concert master of th, series go on sal,- today '. Morris Dailey auditorium thit ir. qa. -peed san Francisco Symphony orchestra, and The!. may also be ! mening at 7:30, according to At Station KQW porch:, . -
What Is Discovery Studio?
Discovery Studio 2.0 Accelrys Life Science Tool 林進中 分子視算 What is Discovery Studio? • Discovery Studio is a complete modelling and simulations environment for Life Science researchers – Interactive, visual and integrated software – Consistent, contemporary user interface for added ease-of-use – Tools for visualisation, protein modeling, simulations, docking, pharmacophore analysis, QSAR and library design – Access computational servers and tools, share data, monitor jobs, and prepare and communicate their project progress – Windows and Linux clients and servers Accelrys Discovery Studio Application Discovery Studio Pipeline ISV Materials Discovery Accord WeWebbPPortort Pipeline ISV Materials Discovery Accord (web Studio Studio (web PilotPilot ClientClient Studio Studio ClientsClients access) (Pro or Lite ) (e.g., Client Client access) (Pro or Lite ) (e.g., Client Client Spotfire) Spotfire) Client Integration Layer SS c c i iT T e e g g i ic c P P l la a t t f f o o r r m m Tool Integration Layer Data Access Layer Cmd-Line Isentris Chemistry Biology Materials Accord Accord IDBS Oracle ISIS Reporting Statistics ISV Tools Databases Pipeline Pilot - Data Processing and Integration • Integration of data from multiple disparate data sources • Integration of disparate applications – Third party vendors and in- house developed codes under the same environment Pipeline Pilot - Data Processing and Integration • Automated execution of routine processes • Standardised data management • Capture of workflows and deployment of best practice Interoperability -
Small Molecule and Protein Docking Introduction
Small Molecule and Protein Docking Introduction • A significant portion of biology is built on the paradigm sequence structure function • As we sequence more genomes and get more structural information, the next challenge will be to predict interactions and binding for two or more biomolecules (nucleic acids, proteins, peptides, drugs or other small molecules) Introduction • The questions we are interested in are: – Do two biomolecules bind each other? – If so, how do they bind? – What is the binding free energy or affinity? • The goals we have are: – Searching for lead compounds – Estimating effect of modifications – General understanding of binding – … Rationale • The ability to predict the binding site and binding affinity of a drug or compound is immensely valuable in the area or pharmaceutical design • Most (if not all) drug companies use computational methods as one of the first methods of screening or development • Computer-aided drug design is a more daunting task, but there are several examples of drugs developed with a significant contribution from computational methods Examples • Tacrine – inhibits acetylcholinesterase and boost acetylcholine levels (for treating Alzheimer’s disease) • Relenza – targets influenza • Invirase, Norvir, Crixivan – Various HIV protease inhibitors • Celebrex – inhibits Cox-2 enzyme which causes inflammation (not our fault) Docking • Docking refers to a computational scheme that tries to find the best binding orientation between two biomolecules where the starting point is the atomic coordinates of the two molecules • Additional data may be provided (biochemical, mutational, conservation, etc.) and this can significantly improve the performance, however this extra information is not required Bound vs. Unbound Docking • The simplest problem is the “bound” docking problem. -
Structure Based Pharmacophore Modeling, Virtual Screening
www.nature.com/scientificreports OPEN Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identifcation of natural anti‑cancer agents targeting XIAP protein Firoz A. Dain Md Opo1,2, Mohammed M. Rahman3*, Foysal Ahammad4, Istiak Ahmed5, Mohiuddin Ahmed Bhuiyan2 & Abdullah M. Asiri3 X‑linked inhibitor of apoptosis protein (XIAP) is a member of inhibitor of apoptosis protein (IAP) family responsible for neutralizing the caspases‑3, caspases‑7, and caspases‑9. Overexpression of the protein decreased the apoptosis process in the cell and resulting development of cancer. Diferent types of XIAP antagonists are generally used to repair the defective apoptosis process that can eliminate carcinoma from living bodies. The chemically synthesis compounds discovered till now as XIAP inhibitors exhibiting side efects, which is making difculties during the treatment of chemotherapy. So, the study has design to identifying new natural compounds that are able to induce apoptosis by freeing up caspases and will be low toxic. To identify natural compound, a structure‑ based pharmacophore model to the protein active site cavity was generated following by virtual screening, molecular docking and molecular dynamics (MD) simulation. Initially, seven hit compounds were retrieved and based on molecular docking approach four compounds has chosen for further evaluation. To confrm stability of the selected drug candidate to the target protein the MD simulation approach were employed, which confrmed stability of the three compounds. Based on the fnding, three newly obtained compounds namely Caucasicoside A (ZINC77257307), Polygalaxanthone III (ZINC247950187), and MCULE‑9896837409 (ZINC107434573) may serve as lead compounds to fght against the treatment of XIAP related cancer, although further evaluation through wet lab is necessary to measure the efcacy of the compounds. -
Getting Started with Rdock Dr
Getting Started with rDock Dr. David Morley Getting Started with rDock Dr. David Morley Copyright © 2006 Vernalis Table of Contents Overview ............................................................................................................ vi 1. Prerequisites ..................................................................................................... 1 2. Unpacking the distribution files ............................................................................ 2 3. Building rDock .................................................................................................. 4 4. Running a short validation experiment ................................................................... 6 iv List of Tables 1.1. Required packages for building and running rDock ................................................ 1 2.1. rDock distribution files ..................................................................................... 2 3.1. Standard tmake build targets provided ............................................................... 4 4.1. Complexes included in the cpu_benchmark experiment ...................................... 6 4.2. rDock score components output as SD data fields .................................................. 7 v Overview rDock is a high-throughput molecular docking platform for protein and RNA targets. Under devel- opment at Vernalis (formerly RiboTargets) since 1998, the software (formerly known as RiboDock1), scoring functions, and search protocols have been refined continuously to meet the de- -
BUDE: GPU-Accelerated Molecular Docking for Drug Discovery
BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem Proteins typically O(1000) atoms ligand Ligands typically O(100) atoms predicted complex receptor 1 Sampling (6-degrees of freedom) EMC 2 Binding affinity prediction EFE-FF 2 An atom-atom based forcefield parameterised according to atom type, analagous to standard molecular mechanics 3 Empirical Free Energy Forcefield McIntosh-Smith, S., et al., Benchmarking Energy Efficiency, Power Costs and Carbon Emissions on Heterogeneous Systems. soft core Computer Journal, 2012. 55(2): p. 192-205. Re-docking a ligand into the Xray Structure (good prediction == low RMSD) 1CIL (Human carbonic anhydrase II) RMSD ~ 0.2 Å 5 Another example 1EZQ (Human Factor XA) RMSD ~ 1.2 Å 6 Accuracy of Pose Prediction (re-docking the BindingDB validation set, 84 complexes) www.bindingdb.org 7 Binding Energy Prediction: is BUDE any better? Mike Hann’s 2006 test of docking software Yes – better but not perfect! 8 BUDE Simplified Flow Diagram (C++/OpenCL) Start BUDE Enter Initial End BUDE Data Yes Data Error(s)? Reading Print Help Yes No Error(s)? Write Control File Prepare Data for Docking No Docking Info Type Docking End BUDE Act on No Option Small Yes Large Error(s)? Site Docking Surface Docking Generate Surface Pairs Calculate Energies Do Docking Print Results No Do Generation Rank Energies Host Job Parallel EMC Code? Score Results Accelerated Job Yes Yes Last No Generation 9 BUDE’s heterogeneous approach 1. Discover all OpenCL platforms/devices, inc. both CPUs and GPUs 2. Run a micro benchmark on each device, ideally a short piece of real work 3.